Feb 25, 2026
The MiniMed Go system combines InPen and Simplera CGM into one powerful app for people with insulin-requiring Diabetes
Feb 23, 2026
The new model is meant to lower upfront costs and expand access, joining the broader industry move toward subscription-style pump access through pharmacies.
Feb 19, 2026
After an initial beta launch, integration of the Eversense 365 continuous glucose monitor has officially launched on the twiist insulin pump.
Feb 18, 2026
Medtronic advances its next-gen tubed pump toward FDA clearance while testing begins on an enhanced algorithm called Vivera.
Feb 17, 2026
The first patients have received its investigational Portal Insulin as development moves toward larger trials in 2027.
Feb 12, 2026
MannKind’s INHALE‐1ST trial is testing an inhaled insulin, as a needle‐free option for children with type 1 diabetes with an expected FDA decision by May 29, 2026.
